Início › Câncer de Bexiga › Flórida
Ensaios clínicos de Câncer de Bexiga em Flórida
38 estudos para Câncer de Bexiga estão buscando participantes em locais em Flórida.
Cidades em Flórida
- Jacksonville10 estudos
- Tampa9 estudos
- Miami8 estudos
- Orlando8 estudos
- St. Petersburg5 estudos
- Gainesville4 estudos
- Cape Coral4 estudos
- Hollywood4 estudos
Texto oficial do estudo (Inglês)
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Mayo Clinic in Florida, Jacksonville
- Moffitt Cancer Center at SouthShore, Ruskin
- Moffitt Cancer Center-International Plaza, Tampa
- e mais 3
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07061964A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Urological Research Network ( Site 0133), Hialeah
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06833073The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Holy Cross Hospital, Fort Lauderdale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- UF Health Cancer Institute - Gainesville, Gainesville
- Mount Sinai Medical Center, Miami Beach
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06770582A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- BRCR Global-Coral Springs, Coral Springs
- Mayo Clinic Florida, Jacksonville
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
- e mais 1
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07277413A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Moffitt Cancer Center at SouthShore, Ruskin
- Moffitt Cancer Center - International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- e mais 3
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07206225DESTINY-PANTUMOUR04
- Research Site, Coral Springs
- Research Site, St. Petersburg
- Research Site, West Palm Beach
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- AdventHealth Orlando, Orlando
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- AdventHealth, Orlando
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06529822Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sylvester Comprehensive Cancer Center - Miami, Miami
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05267626ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Moffitt Cancer Center, Tampa
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07144319A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06760819Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- University of Florida, Gainesville
- Mayo Clinic Florida, Jacksonville
- Advanced Urology Institute (Solaris), Largo
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06567743Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- e mais 11
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05334069Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Mayo Clinic, Jacksonville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Advent Health, Orlando
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- UM Sylvester Comprehensive Cancer Center at Doral, Doral
- e mais 5
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07097142A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of Florida, Jacksonville
- Sylvester Comprehensive Cancer Center / University of Miami Hospital and Clinics, Miami
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT04752722Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- UF Health Cancer Institute - Gainesville, Gainesville
- Mayo Clinic in Florida, Jacksonville
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07000084Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
- H. Lee Moffitt Cancer Center & Research Institute, Tampa
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT07225127Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
- Moffitt Cancer Center, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT06963346Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Miami Cancer Institute at Baptist Health, Inc., Miami
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Miami Hospital and Clinics, Miami
RecrutandoFase 2
Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Florida Cancer Specialists, Bonita Springs
- Florida Cancer Specialists, Bradenton
- Florida Cancer Specialists, Bradenton
- e mais 14
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT04879329A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- American Oncology Partners, PA. a Florida professional service corporation, d/b/a Vista Oncology, Fort Myers
- Florida Cancer Specialists & Research Institute, LLC, Fort Myers
- Memorial Cancer Institute, Hollywood
- e mais 4
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT04389632Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Advanced Urology Institute - Daytona Beach, Daytona Beach
Recrutando
Idades de 18 a 88 · Todos os sexos · Atualizado em 2 de jul. de 2026 · NCT06394869Integrated Cancer Repository for Cancer Research
- Florida Hospital Memorial Medical Center, Daytona Beach
- Florida Hospital DeLand, DeLand
- Florida Hospital FISH, Orange City
- e mais 2
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
- Mayo Clinic in Florida, Jacksonville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de mar. de 2026 · NCT06704191Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
- University of Florida, Gainesville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de mar. de 2026 · NCT06488222Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Florida Cancer Specialists-Lake Nona, Orlando
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de fev. de 2026 · NCT07030257A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT06778863cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Miami Cancer Institute, Miami
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774A Beta-only IL-2 ImmunoTherapY Study
- Boca Raton Regional Hospital, Boca Raton
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2025 · NCT05086692Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.